✦ LIBER ✦

The SUCCESS-Trial -toxicity analysis of a phase III study evaluating the role of Docetaxel and Gemcitabine in the adjuvant therapy of breast cancer patients

✍ Scribed by W. Janni; E. Genss; B. Rack; H. Sommer; M. Rezai; A. Schneider; W. Lichtenegger; M. Beckmann; A. Schneeweiss; K. Friese

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III study evaluating the role of d

✍ B. Rack; W. Janni; N. Harbeck; I. Zemzoun; B. Strobl; E. Klanner; J. de Waal; C. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 201 KB

Pharmacoeconomic Analysis Of Docetaxel I

✍ Zinchuk, I.; Yagudina, R.; Kulikov, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

P70 The ADEBAR-trial — participation in

✍ J.W. Janni; H. Sommer; B. Rack; D. Steinfeld; D. Augustine; M. Heinrigs; K. Gaug 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Biweekly docetaxel and gemcitabine as ne

✍ L. G. Estévez; P. Sánchez-Rovira; M. Dómine; A. León; I. Calvo; A. Jaén; V. Casa 📂 Article 📅 2007 🏛 Springer Milan 🌐 Spanish ⚖ 80 KB

P73 Phase III study evaluating the role

✍ M. Heinrigs; H. Sommer; B. Rack; W. Janni; N. Harbeck; D. Steinfeld; D. Augustin 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Participation in phase III ADEBAR: evalu

✍ F von Bismarck; W Janni; B Rack; W Thieleke; B Strobl; D Steinfeld; D Augustin; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 160 KB